BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25828518)

  • 21. Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.
    Banno K; Yanokura M; Kawaguchi M; Kuwabara Y; Akiyoshi J; Kobayashi Y; Iwata T; Hirasawa A; Fujii T; Susumu N; Tsukazaki K; Aoki D
    Int J Oncol; 2007 Oct; 31(4):713-20. PubMed ID: 17786301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
    Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng Z; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF
    Int J Cancer; 2003 Jan; 103(2):153-60. PubMed ID: 12455028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods.
    Cheng ZD; Hu SL; Sun YB; Xu WP; Shen G; Kong XY
    Chin J Cancer; 2010 Feb; 29(2):163-6. PubMed ID: 20109344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
    Yoshida K; Hamai Y; Suzuki T; Sanada Y; Oue N; Yasui W
    Anticancer Res; 2006; 26(1A):49-54. PubMed ID: 16475678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
    Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
    Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
    Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes.
    Koga T; Takeshita M; Ijichi K; Yano T; Maehara Y; Sueishi K
    Hum Pathol; 2013 Jul; 44(7):1382-90. PubMed ID: 23415374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
    Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
    Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
    Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV
    Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
    Brodie SA; Li G; Brandes JC
    Respir Med; 2015 Jan; 109(1):131-6. PubMed ID: 25477232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression of the CHFR prophase checkpoint gene in human B-cell non-Hodgkin lymphoma.
    Song A; Ye J; Zhang K; Yu H; Gao Y; Wang H; Sun L; Xing X; Yang K; Zhao M
    Leuk Res; 2015 May; 39(5):536-43. PubMed ID: 25798877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers.
    Kang HC; Kim IJ; Park JH; Shin Y; Park HW; Ku JL; Yang HK; Lee KU; Choe KJ; Park JG
    Oncol Rep; 2004 Jul; 12(1):129-33. PubMed ID: 15201973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT; Lee SH; Sung SW; Kim JH
    Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.
    Mizuno K; Osada H; Konishi H; Tatematsu Y; Yatabe Y; Mitsudomi T; Fujii Y; Takahashi T
    Oncogene; 2002 Apr; 21(15):2328-33. PubMed ID: 11948416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation of multiple genes and clinicopathological relationship of non-small cell lung cancers.
    Hanabata T; Tsukuda K; Toyooka S; Yano M; Aoe M; Nagahiro I; Sano Y; Date H; Shimizu N
    Oncol Rep; 2004 Jul; 12(1):177-80. PubMed ID: 15201980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of apoptosis-associated speck-like protein containing a CARD gene promoter methylation in resectable non-small-cell lung cancer.
    Zhang Z; Tan S; Zhang L
    Clin Lung Cancer; 2006 Jul; 8(1):62-5. PubMed ID: 16870048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
    Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L
    Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.